Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha
- PMID: 16405514
- DOI: 10.1111/j.1471-4159.2005.03566.x
Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha
Abstract
Activated microglia are implicated in the pathogenesis of disease-, trauma- and toxicant-induced damage to the CNS, and strategies to modulate microglial activation are gaining impetus. A novel action of the tetracycline derivative minocycline is the ability to inhibit inflammation and free radical formation, factors that influence microglial activation. Minocycline is therefore being tested as a neuroprotective agent to alleviate CNS damage, although findings so far have yielded mixed results. Here, we showed that administration of a single low dose of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or methamphetamine (METH), a paradigm that causes selective degeneration of striatal dopaminergic nerve terminals without affecting the cell body in substantia nigra, increased the expression of mRNAs encoding microglia-associated factors F4/80, interleukin (IL)-1alpha, IL-6, monocyte chemoattractant protein-1 (MCP-1, CCL2) and tumor necrosis factor (TNF)-alpha. Minocycline treatment attenuated MPTP- or METH-mediated microglial activation, but failed to afford neuroprotection. Lack of neuroprotection was shown to be due to the inability of minocycline to abolish the induction of TNF-alpha and its receptors, thereby failing to modulate TNF signaling. Thus, TNF-alpha appeared to be an obligatory component of dopaminergic neurotoxicity. To address this possibility, we examined the effects of MPTP or METH in mice lacking genes encoding IL-6, CCL2 or TNF receptor (TNFR)1/2. Deficiency of either IL-6 or CCL2 did not alter MPTP neurotoxicity. However, deficiency of both TNFRs protected against the dopaminergic neurotoxicity of MPTP. Taken together, our findings suggest that attenuation of microglial activation is insufficient to modulate neurotoxicity as transient activation of microglia may suffice to initiate neurodegeneration. These findings support the hypothesis that TNF-alpha may play a role in the selective vulnerability of the nigrostriatal pathway associated with dopaminergic neurotoxicity and perhaps Parkinson's disease.
Similar articles
-
Defining "neuroinflammation".Ann N Y Acad Sci. 2008 Oct;1139:318-30. doi: 10.1196/annals.1432.032. Ann N Y Acad Sci. 2008. PMID: 18991877
-
Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha.FASEB J. 2006 Apr;20(6):670-82. doi: 10.1096/fj.05-5106com. FASEB J. 2006. PMID: 16581975
-
Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease.FASEB J. 2002 Sep;16(11):1474-6. doi: 10.1096/fj.02-0216fje. Epub 2002 Jul 18. FASEB J. 2002. PMID: 12205053
-
Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease.Med Sci Monit. 2005 Jan;11(1):RA17-23. Med Sci Monit. 2005. PMID: 15614202 Review.
-
Developmental and genetic influences upon gender differences in methamphetamine-induced nigrostriatal dopaminergic neurotoxicity.Ann N Y Acad Sci. 2004 Oct;1025:205-20. doi: 10.1196/annals.1316.026. Ann N Y Acad Sci. 2004. PMID: 15542719 Review.
Cited by
-
Differentiation and regulation of CD4+ T cell subsets in Parkinson's disease.Cell Mol Life Sci. 2024 Aug 17;81(1):352. doi: 10.1007/s00018-024-05402-0. Cell Mol Life Sci. 2024. PMID: 39153043 Free PMC article. Review.
-
Virus-Induced Epilepsy vs. Epilepsy Patients Acquiring Viral Infection: Unravelling the Complex Relationship for Precision Treatment.Int J Mol Sci. 2024 Mar 27;25(7):3730. doi: 10.3390/ijms25073730. Int J Mol Sci. 2024. PMID: 38612542 Free PMC article. Review.
-
Exploring the Potential of Aptamers in Targeting Neuroinflammation and Neurodegenerative Disorders: Opportunities and Challenges.Int J Mol Sci. 2023 Jul 22;24(14):11780. doi: 10.3390/ijms241411780. Int J Mol Sci. 2023. PMID: 37511539 Free PMC article. Review.
-
Neuron-astrocyte omnidirectional signaling in neurological health and disease.Front Mol Neurosci. 2023 Jun 8;16:1169320. doi: 10.3389/fnmol.2023.1169320. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37363320 Free PMC article. Review.
-
Voltage-Gated Proton Channel Hv1 Regulates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson's Disease Models.Antioxidants (Basel). 2023 Feb 25;12(3):582. doi: 10.3390/antiox12030582. Antioxidants (Basel). 2023. PMID: 36978830 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous